Needham Initiates Coverage On Bioage Labs with Buy Rating, Announces Price Target of $50
Benzinga Newsdesk 7 months ago
NewsPrice TargetInitiationAnalyst Ratings
Needham analyst Joseph Stringer initiates coverage on Bioage Labs (NASDAQ:BIOA) with a Buy rating and announces Price Target of $50.
Needham analyst Joseph Stringer initiates coverage on Bioage Labs (NASDAQ:BIOA) with a Buy rating and announces Price Target of $50.